Panacea Biotec and RDIF to Produce 100 Million Sputnik V vaccine Doses Yearly
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Panacea Biotec, India’s largest vaccine and pharmaceutical manufacturer, have
Read moreThe Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Panacea Biotec, India’s largest vaccine and pharmaceutical manufacturer, have
Read moreContract Development and Manufacturing Organization Celonic and German biopharmaceutical company CureVac have entered into an agreement to manufacture 100 Million
Read moreJohnson & Johnson has started vaccinating teens aged 12 to 17 in the ongoing Phase 2a clinical trial for its
Read moreGSK has made an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support the production of
Read moreNew data from a Phase 3 Study has shown that the investigational monoclonal antibody cocktail of casirivimab and imdevimab has
Read moreCureVac intends to expand its COVID-19 vaccine candidate clinical trial in order to be able to determine efficacy for select
Read moreThermo Fisher Scientific has entered into a collaboration agreement with Artificial to enable improved integration of software and robotics platforms
Read moreThe European Commission (EC) approval of Johnson & Johnson’s vaccine has paved the way for EU nations to use the
Read moreAstraZeneca COVID-19 vaccine inoculations are being put on pause in Denmark, as well as Norway, Iceland, and Luxembourg over adverse
Read moreAdienne Pharma & Biotech has signed an agreement for the manufacture of Russia’s Sputnik V COVID-19 vaccine. This paves the
Read more